Cibus Q4 loss $31.9M; cash $9.9M; Jan 2026 offering $22.3M; exploring strategic alternatives

Cibus, Inc.

Cash and equivalents $9.9M at Dec 31, 2025; with $19.8M net Jan 2026 offering, runway into late Q3 2026.
Q4 net loss $31.9M ($0.59/share) vs $25.8M a year ago; includes $9.1M non-cash impairment of Roseville facility.
Raised $22.3M gross ($19.8M net) in January 2026 public offering to fund rice trait advancement.
Board evaluating strategic alternatives to maximize shareholder value; no definitive actions announced.
Rice program on track for 2027/2028 commercial launches; sustainable ingredients received first customer payment in Q4 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.